Modular and Flexible PCR Instrumentation
HERCULES,
Calif., January 21, 2008 – Bio-Rad
Laboratories, Inc. (AMEX: BIO and BIOb), a multinational manufacturer and
distributor of life science research and clinical diagnostic products, today
announced the introduction of the Bio-Rad 1000-series
thermal cycling platform, its next generation
PCR instrumentation.
The C1000™ and S1000™ thermal cyclers
offer a flexible and modular high-end PCR platform, with features giving performance
that is fast, accurate, and reproducible. The C1000 incorporates the best of
the iCycler®,system including a large graphical display and the best
of the DNA Engine including its fully adjustable lid. The C1000 also includes
features such as USB flash drive data storage and the Protocol Autowriter that enables
users to automatically write protocols based on their input parameters and the
desired reaction speed.
“We are excited to add these next generation thermal
cyclers to our range of PCR solutions,” said Hilary Srere, Bio-Rad’s PCR
amplification marketing manager. “The C1000 and S1000 thermal cyclers give
users the flexibility to work the way they want to work, with options for
programming and the ability to support a wide range of consumables. At the same
time they will get best-in-class thermal performance and adherence to the most
stringent quality standards.”
Unlike thermal
cyclers from other manufacturers, the C1000 and S1000 thermal cyclers offer
multiple block formats including 96-well fast, 384-well, and a dual 48-well fast block that is gradient enabled. Bio-Rad
is the only manufacturer to offer a gradient enabled dual block. Additionally,
the C1000 can be upgraded to real-time PCR with the CFX96™ reaction
module.
The 1000-series offers scientists technology that helps them achieve faster results. In addition, the 1000-series offers easy integration into existing workflows and has multiple features that focus on the user such as easy-to-use software, PC compatibility, single-run optimization with thermal gradient, automatic programming, multiple connectivity options, and online training and tools.
About Bio-Rad
Bio-Rad Laboratories, Inc. (AMEX: BIO and BIOb) has remained at the center of
scientific discovery for more than 50 years manufacturing and distributing a
broad range of products for the life science research and clinical diagnostic
markets. The company is renowned worldwide among hospitals, universities, major
research institutions, as well as biotechnology and pharmaceutical companies
for its commitment to quality and customer service. Founded in 1952, Bio-Rad is
headquartered in Hercules, California, and serves more than 85,000 research and
industry customers worldwide through its global network of operations. The
company employs approximately 6,300 people
globally and had revenues of nearly $1.3 billion in 2006. For more information,
visit www.bio-rad.com.
This release contains certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements generally can be identified by the use of forward-looking terminology such as, “believe,” “expect,” “may,” “will,” “intend,” “estimate,” “continue,” or similar expressions or the negative of those terms or expressions. Such statements involve risks and uncertainties, which could cause actual results to vary materially from those expressed in or indicated by the forward-looking statements. For further information regarding the Company's risks and uncertainties, please refer to the “Risk Factors” in the Company’s public reports filed with the Securities and Exchange Commission, including the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2006, as updated by subsequent Quarterly Reports on Form 10-Q and Current Reports on Form 8-K. The Company cautions you not to place undue reliance on forward-looking statements, which reflect an analysis only and speak only as of the date hereof. Bio-Rad Laboratories, Inc. disclaims any obligation to update these forward-looking statements.
NOTE TO THE EDITOR:
For an html link to this news or to
download a product image please visit the following URL: http://www.alchymiacomm.com/NewsReleasesPhotography.html
NB: If you have
difficulty downloading the image please contact Doug Forsyth. Alchymia Communications® LLC, 541-482-8744,
df@alchymiacomm.com
Information in this release applies
specifically to products available in the United States. Product availability
and specifications may vary in non‑U.S. markets.
If you choose to review this item, your readers will receive the quickest response to their inquiries by e‑mailing them to lsg.orders.us@bio-rad.com or by calling 1-800-424-6723.
For more
information contact:
Hilary Srere
Bio-Rad Laboratories, Inc.
510-724-7000
Doug Forsyth
Alchymia Communications® LLC
541-482-8744